Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
|Product:||Mometasone Allergy Relief|
Mometasone furoate monohydrate 0.5173mg/g equivalent to mometasone furoate
|Dosage Form:||Nasal spray solution|
|New Zealand Sponsor:||PSM Healthcare Limited trading as API Consumer Brands|
|Manufacturer:||Farmea, Angers, France|
Cinchocaine hydrochloride 5mg/g
|Dosage Form:||Rectal ointment|
|New Zealand Sponsor:||Nova Pharmaceuticals NZ Limited|
|Manufacturer:||Mepro Pharmaceuticals Private Limited, Wadhwan City, India|
Dated this 31st day of May 2021.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).